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1 These authors contributed equally to this work.The ubiquitin-like modiﬁer FAT10 targets proteins for degradation by the proteasome, a process
accelerated by the UBL-UBA domain protein NEDD8 ultimate buster 1-long. Here, we show that
FAT10-mediated degradation occurs independently of poly-ubiquitylation as puriﬁed 26S protea-
some readily degraded FAT10-dihydrofolate reductase (DHFR) but not ubiquitin-DHFR in vitro.
Interestingly, the 26S proteasome could only degrade FAT10-DHFR when NUB1L was present.
Knock-down of NUB1L attenuated the degradation of FAT10-DHFR in intact cells suggesting that
NUB1L determines the degradation rate of FAT10-linked proteins. In conclusion, our data establish
FAT10 as a ubiquitin-independent but NUB1L-dependent targeting signal for proteasomal
degradation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The 26S proteasome is responsible for the turnover of most pro-
teins in eukaryotes. Proteins are targeted for proteasomal degrada-
tion by the covalent attachment of a chain of ubiquitin molecules.
Substrate recognition by the proteasome is mediated by ﬁve sub-
units of the 19S regulator: S5a/Rpn10, S60/Rpt5, and Rpn13/ARM1
which directly recruit K48-linked polyubiquitin chains as well as
S1/Rpn2 and S2/Rpn1, which indirectly recognize substrates by
binding to linker proteins such as Rad23/hHR23 and Dsk2/hPLIC
[1]. Besides this canonical mode of proteasomal degradation, a
few alternative routes into the proteasome exist. The most promi-
nent case is that of ornithine decarboxylase (ODC), the rate-limit-
ing enzyme in the synthesis of polyamines. Cellular ODC levels
are controlled through a negative feedback mechanism involving
the polyamine-induced inhibitor antizyme (AZ) [2].
A different case is that of the ubiquitin-like modiﬁer FAT10,
which encompasses two ubiquitin-like domains. FAT10 lies en-
coded in the major histocompatibility complex class I locus and
is inducible with IFN-c and TNF-a [3,4]. FAT10 is activated by
the E1 enzyme UBA6 (E1-L2, UBE1L2) and becomes conjugated tochemical Societies. Published by E
e reductase; NUB1L, NEDD8
e (M. Groettrup).so far unidentiﬁed target proteins through a free diglycine-motif
at its C-terminus [5,6]. N-terminal fusions of FAT10 to long-lived
proteins such as GFP and dihydrofolate reductase (DHFR) are de-
graded with a kinetic similar to that of ubiquitin-fusions while
SUMO-1 fusions remain stable suggesting that FAT10 serves as a
signal for proteasomal degradation [7,8]. Degradation of FAT10
and FAT10-linked proteins can be further accelerated by the UBL-
UBA domain protein NEDD8 ultimate buster 1-long (NUB1L),
which interacts with both FAT10 and the 26S proteasome [8].
A pertinent question is whether FAT10 can mediate proteaso-
mal degradation independently of the ubiquitin system. Two ap-
proaches have been used to address this issue in intact cells: the
ﬁrst was the mutation of all 17 lysine residues to arginine which
did not affect proteasomal degradation of FAT10 [8]. Although
we could not detect any ubiquitylation of lysineless FAT10, one
can not exclude that residual ubiquitylation of the N-terminus of
FAT10 below detection level may contribute to proteasome target-
ing. The second approach was the investigation of FAT10 degrada-
tion in E36ts20 cells, which bear a temperature sensitive mutation
of the ubiquitin activating enzyme UBE1. In these cells FAT10 deg-
radation was normal at the restrictive temperature [8]. However,
the recent discovery of UBA6 as a second ubiquitin activating en-
zyme [9,10,6] opens the possibility that ubiquitylation of FAT10 re-
lies on UBA6 thus rendering experiments in ts20 cells inconclusive.
Here, we have addressed whether FAT10 can target a protein to
the 26S proteasome independently of ubiquitylation in vitro. We
found that an N-terminal FAT10-DHFR fusion protein can belsevier B.V. All rights reserved.
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presence of NUB1L. The herein presented results conclusively show
the ubiquitin-independence of FAT10-mediated degradation and,
given that FAT10 can also directly interact with the proteasome
[11], allow the conclusion that mere association of FAT10 with
the 26S proteasome is not enough to promote its degradation.
2. Materials and methods
2.1. Proteasome puriﬁcation
Puriﬁcation of the 20S proteasome was performed as described
elsewhere [11], the 26S proteasome was puriﬁed as previously de-
scribed [12] with modiﬁcations as outlined in the Supplementary
material.
2.2. In vitro degradation assays
Protein degradation assays were performed as previously out-
lined [12] with some modiﬁcations. The assays were performed
in 50-ll reaction volumes at 37 C for one hour and contained
50 mM Tris–HCl, pH 7.5, 5 mM MgCl2, 1 mM ATP, 20% glycerol,
an ATP regenerating system (2 mM dithiothreitol, 10 mM creatine
phosphate, 1.6 mg/ml creatine kinase), 1 mg/ml acetylated bovine
serum albumin (Promega) and proteasomes. Reactions were initi-
ated by addition of substrate (usually 20000 cpm) and quenched
by addition of 50 ll of 20% (w/v) trichloroacetic acid. The insoluble
material was removed by centrifugation (14000g, 15 min), and
3  30 ll of the supernatant were measured in a scintillation coun-
ter. Percentage degradation of radiolabeled proteins was deter-
mined as the released counts/min divided by total input in
counts/min. Background counts/min were determined in reactions
devoid of proteasomes, and were typically 1–3% of total input
counts.
2.3. Western blot and immunoprecipitation
Determination of NUB1L expression was performed by western
blotting using anti-NUB1L peptide antibodies provided by Biomol
and Dr. Michal E. Cheetham (London) [13]. Cells were harvested,
washed, and lysed in 200 ll 50 mM Tris–HCl, pH 7.8, 0.01% SDS.
After sonication and centrifugation, the supernatant was removed
and the OD at 280 nm determined. Lysates were diluted to an
OD280 of 0.15 and 10, 5 and 1 ll was loaded onto SDS–PAGE. As a
loading control the HSP90-speciﬁc antibody H-114 (Santa Cruz
Biotechnology) was used. Cultivation and transfection of HeLa-
cells, pulse-chase analysis, immunoprecipitation, SDS–PAGE and
audioradiography have been described before [7].Fig. 1. Puriﬁed components for in vitro degradation. (A) Silver stained SDS–gel of
puriﬁed 26S proteasome (about 500 ng), puriﬁed 20S proteasome (about 250 ng)
and the recombinant proteins NUB1L, antizyme, ornithine decarboxylase (ODC),
GST-FAT10, ubiquitin-dihydrofolate reductase (Ub-DHFR) and FAT10–DHFR
(between 10 and 50 ng each). (B) Autoradiogram of radioactively labelled ODC,
GST-FAT10, Ub-DHFR, and FAT10-DHFR.3. Results and discussion
3.1. Degradation of FAT10-DHFR in vitro is independent of
ubiquitylation but relies on NUB1L
In order to investigate whether puriﬁed 26S proteasome can de-
grade a FAT10-linked protein in the absence of ubiquitylation we
used an N-terminal fusion of FAT10 to DHFR as a model substrate,
because Ub5-DHFR can be degraded by the 26S proteasome in vitro
[14] and because an HA-FAT10-DHFR fusion protein was degraded
in a proteasome-dependent manner in intact cells [8]. To exclude
any residual ubiquitylating activity in our reactions, we decided
on Ub-DHFR as a negative control. Ub-DHFR is readily polyubiqui-
tylated and degraded by the proteasome [8,15], however, a single
ubiquitin moiety is insufﬁcient to promote degradation by 26S
proteasomes in vitro [14]. A C-terminal fusion of FAT10 to GST(GST-FAT10) was also included as a test substrate because the C-
terminal attachment of K48R mutated ubiquitin to DHFR left this
substrate relatively stable compared to the degradation of an N-
end rule substrate [16].
FAT10-DHFR, Ub-DHFR, and GST-FAT10 were produced in
Escherchia coli and metabolically labeled with [35S]-methionine.
Degradation was measured by the release of acid soluble counts
and was linear over time (data not shown). [35S]-labeled, in vitro
transcribed/translated and afﬁnity-puriﬁed ODC served as the po-
sitive control for degradation. The proteinaceous components of
our in vitro degradation assays are depicted in Fig. 1. In panel A
a silver staining of the puriﬁed proteins is shown while in panel
B the autoradiogram of the same proteins is presented.
Degradation of ODC already occured to a minor extent when
incubated with 26S proteasome alone (Fig. 2A, compare bars 1
and 3) and could be increased by the addition of AZ (Fig. 2A, bar
4). Incubation with 5 lM of the proteasome inhibitor epoxomicin
reduced degradation to background levels (Fig. 2A, bar 5). Fig. 2B
reveals our assay to be devoid of ubiquitylating activity, as Ub-
DHFR was not degraded by the proteasome under any of the con-
ditions investigated.
Previously, we showed that FAT10 directly binds the 26S pro-
teasome [11], however, incubation of FAT10-DHFR with 26S pro-
teasome alone was insufﬁcient to promote its degradation
(Fig. 2C, bar 2) which was as low as in the presence of epoxomicin
(Fig. 2C, bar 5). Remarkably, the addition of puriﬁed, recombinant
NUB1L induced degradation of FAT10-DHFR by the 26S protea-
some in a dose-dependent manner (Fig. 2C, bars 3 and 4). In con-
trast, FAT10-DHFR was completely stable when incubated with
puriﬁed 20S proteasome (Fig. 2C, bars 8 and 9). Experiments with
GST-FAT10 showed that C-terminal fusion of FAT10 was insufﬁ-
cient to promote degradation of GST despite the ability of GST-
FAT10 to interact with both NUB1L and the 26S proteasome
in vitro ([7,11] and data not shown).
Fig. 2. Degradation of FAT10-DHFR by the 26S proteasome in vitro is independent
of ubiquitylation but relies on NUB1L. The Y-axis always represents percent of acid
soluble counts released per hour. The in vitro reactions were performed with the
components indicated above each panel. Inhib. refers to degradation occurring in
the presence of 5 lM of the speciﬁc proteasome inhibitor epoxomicin. (A) Antizyme
(AZ)-dependent degradation of ornithine decarboxylase (ODC) as positive control
for 26S proteasome activity. (B) Ubiquitin-DHFR (Ub-DHFR) is not signiﬁcantly
degraded by the puriﬁed 26S proteasome. (C) NUB1L-dependent degradation of
FAT10-DHFR by puriﬁed 26S proteasome. A plus sign in brackets (+) and a non-
bracketed + sign designate degradation in the presence of low (2 ng) and high
(20 ng) amounts of NUB1L, respectively.
Fig. 3. Efﬁcient knock down of NUB1L in stable HeLa transfectants expressing two
NUB1L shRNAs. Shown are western blots of wild type HeLa-cells (WT) and three
different stable transfectants expressing two NUB1L speciﬁc shRNAs (clones F9, G6
and H10). 10, 5, and 1 ll of cell lysate (indicated above the panels) were loaded for
each cell type. (A and C) Western blots probed with two different NUB1/NUB1L
peptide-speciﬁc antibodies (A, Ref. [13]; C, Biomol). The arrowheads show the
position of NUB1L. (B and D) Loading control for panels A and C with anti-HSP 90
antibody, respectively.
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To determine whether NUB1L is essential for the degradation of
FAT10-DHFR in vivo, we generated HeLa cell transfectants stablyexpressing two shRNAs directed against NUB1L. Based on quantita-
tive RT-PCR analysis, we selected three clones for pulse-chase
experiments with knock-down efﬁciencies of 91.2% (clone G6),
90.5% (clone F9) and 89.1% (clone H10), respectively. Western blots
of cell lysates probed with two different antibodies against NUB1
as well as an anti-HSP90 antibody as loading control revealed
faintly detectable levels of NUB1L protein in only one of the clones
(F9) and with only one of the antibodies (Fig. 3A and C). Densito-
metric evaluation of the NUB1L bands obtained by three dilutions
of lysates on graded western blots (Fig. 3A) revealed that the resid-
ual expression of NUB1L protein in the shRNA transfectants was 2%
(G6), 8.5% (F9), and 4% (H10), respectively.
Next, we transiently transfected the three NUB1L knock-down
clones and HeLa-cells with an expression construct for HA-
FAT10-DHFR and monitored its degradation in pulse-chase exper-
iments. As shown in Fig. 4, the degradation of HA-FAT10-DHFR was
markedly slowed down in the three NUB1L knock-down clones
compared to HeLa-cells and the reduction in HA-FAT10-DHFR deg-
radation correlated with the extent of NUB1L deﬁciency. This result
strongly suggests that also in intact cells, NUB1L is required to sup-
port the degradation of FAT10-linked proteins by the proteasome.
Degradation by the proteasome can be divided into two catego-
ries: inducible destruction, which is chieﬂy mediated by attach-
ment of a K48-linked polyubiquitin chain to target proteins, and
degradation of proteins which contain intrinsic targeting signals.
Proteins with loosely folded domains can be degraded by the 20S
proteasome without the need for ubiquitylation or ATP-dependent
unfolding. The structure of FAT10 remains yet to be solved, how-
ever, the high sequence similarity to ubiquitin and ISG15 suggests
that it is composed of two ubiquitin-fold domains [17], which are
anything but loosely folded. One can thus safely assume that FAT10
has evolved as a component of a specialized regulatory system
responsible for targeting a subset of proteins for proteasomal deg-
radation, and is not merely degraded due to an intrinsic instability.
This notion is further supported by the ﬁnding that puriﬁed 20S
proteasome was unable to degrade FAT10-DHFR in vitro (Fig. 2C),
and that C-terminal attachment of FAT10 did not promote degra-
dation (data not shown).
The important role for NUB1L in mediating the degradation of
FAT10-linked proteins in vitro has been conﬁrmed in three
Fig. 4. Knock down of NUB1L attenuates the degradation of HA-FAT10-DHFR. (A)
Shown are autoradiograms of HA-FAT10-DHFR immunoprecipitations from HeLa-
cells (WT) and the NUB1L shRNA transfected clones G6, F9, und H10 described in
Fig. 3. Cells were pulse labeled with [35S]-Met/Cys for one hour and chased for the
indicated time periods (in h). (B) Graphic representation of the phosphorimager-
assisted quantitative evaluation of three different experiments as exempliﬁed in
panel A; the extent of FAT10 degradation in percent is plotted versus the chase
time. Shown are the mean ± S.D. for HeLa wild type cells (diamonds), and the
transfectants F9 (dots), H10 (triangles), and G6 (cubes).
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shRNAs each. Compared to the parental cells, the degradation rate
of HA-FAT10-DHFR was reduced by approximately 50% (Fig. 4)
thus indicating that the expression of NUB1L mRNA and protein,
which was reduced by over 90%, became a rate-limiting factor
for HA-FAT10-DHFR degradation (Fig. 3). It hence appears, that
both in vitro and in vivo, NUB1L is indispensable for normal degra-
dation of FAT10-DHFR. We have shown previously that the N-ter-
minal ubiquitin-like domain of NUB1L is required for the
acceleration of FAT10 degradation and we speculate that binding
of this domain to the 26S proteasome induces a conformational
change in the 19S regulator which speciﬁcally facilitates degrada-
tion of FAT10-modiﬁed substrates while the degradation of poly-
ubiquitylated proteins is not affected [11].
Combined with our studies on FAT10 degradation in ts20 cells
and the fact that deletion of all lysines of FAT10 had no effect on
FAT10 degradation [8], the present in vitro studies establish
FAT10 as the second member of the ubiquitin family that serves
as an autonomous signal for targeting proteins for degradation
by the 26S proteasome.Acknowledgements
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